Michael Menzel

Goddard Space Flight Center — United States

Agricultural and Biological Sciences · Life Sciences

35h-index4.1kcitations133works9.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bat Biology and Ecology Studies(32), Service-Oriented Architecture and Web Services(28), Cloud Computing and Resource Management(20), Access Control and Trust(17), Cancer Genomics and Diagnostics(14)

Publications131 total

Whole Exome Sequencing on FHIR: Towards Adoption in Clinical Practice for Precision Oncology Pipelines
Studies in health technology and informatics·2025Open Access
155eP Microcosting analysis of combined whole genome sequencing and whole transcriptome sequencing in cancer diagnostics
ESMO Open·2025Open Access
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer
Communications Biology·2025Open Access
James Webb Space Telescope: Lessons Learned and Applications to Future Flagships
SPIE eBooks·2025
Abstract 2057: CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer
Cancer Research·2025
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test
Journal of Molecular Diagnostics·2024· 4 citedOpen Access
131P Benchmarking whole exome sequencing in the German network for personalized medicine
ESMO Open·2024Open Access
Benchmarking whole exome sequencing in the German network for personalized medicine
European Journal of Cancer·2024· 4 citedOpen Access
Tumour mutational burden: clinical utility, challenges and emerging improvements
Nature Reviews Clinical Oncology·2024· 94 cited
Tumor purity as confounder for the determination of tumor mutational burden (TMB).
Journal of Clinical Oncology·2024
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor
Journal of Molecular Diagnostics·2024Open Access
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer
JCO Precision Oncology·2024· 15 citedOpen Access
Genomic heterogeneity at baseline is associated with <scp>T790M</scp> resistance mutations in <i>EGFR</i>‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors
The Journal of Pathology Clinical Research·2024· 5 citedOpen Access
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients
npj Precision Oncology·2023· 28 citedOpen Access
Erratum: Molekulare Tumordiagnostik als Triebfeder der Präzisionsonkologie
DMW - Deutsche Medizinische Wochenschrift·2023
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)
Translational Oncology·2023· 15 citedOpen Access
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis
Cell Death Discovery·2023· 7 citedOpen Access
Abstract 2607: Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by comprehensive mRNA expression analysis
Cancer Research·2023
Leveraging Off-Target Reads in Panel Sequencing: A Comprehensive Technical Pilot Study
SSRN Electronic Journal·2023Open Access
Abstract 810: HRD is inversely correlated with MSI and identifies immunologically cold tumors in most cancer types
Cancer Research·2022
page 1 of 7Next →

Frequent Co-authors

W. Mark Ford(19), Jennifer M. Menzel(13), John W. Edwards(11), Brian R. Chapman(10), Timothy C. Carter(9), Christoph Meinel(7), W. Mark Ford(6), John C. Kilgo(5), Joshua Laerm(5), Rajiv Ranjan(5), Sheldon F. Owen(5), Karl V. Miller(5), Petra Bohall Wood(4), Timothy S. McCay(3), Ivonne Thomas(3), Stefan Tai(3), Jan Budczies(3), Daniel Kazdal(3), Klaus Kluck(3), Michael Allgäuer(3)